Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disease modification in osteoarthritis; pathways to drug approval.
Katz JN, Neogi T, Callahan LF, Block JA, Conaghan PG, Simon LS, Kraus VB, Hochberg MC. Katz JN, et al. Among authors: simon ls. Osteoarthr Cartil Open. 2020 Mar 10;2(2):100059. doi: 10.1016/j.ocarto.2020.100059. eCollection 2020 Jun. Osteoarthr Cartil Open. 2020. PMID: 36474586 Free PMC article.
Toward designing human intervention studies to prevent osteoarthritis after knee injury: A report from an interdisciplinary OARSI 2023 workshop.
Whittaker JL, Kalsoum R, Bilzon J, Conaghan PG, Crossley K, Dodge GR, Getgood A, Li X, Losina E, Mason DJ, Pietrosimone B, Risberg MA, Roemer F, Felson D, Culvenor AG, Meuffels D, Gerwin N, Simon LS, Lohmander LS, Englund M, Watt FE. Whittaker JL, et al. Among authors: simon ls. Osteoarthr Cartil Open. 2024 Feb 23;6(2):100449. doi: 10.1016/j.ocarto.2024.100449. eCollection 2024 Jun. Osteoarthr Cartil Open. 2024. PMID: 38440780 Free PMC article.
Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial.
Malone A, Kowalski MM, Helliwell J, Lynggaard Boll S, Rovsing H, Moriat K, Castillo Mondragón A, Li Y, Prener Miller C, Reinstrup Bihlet A, Dobek C, Peck V, Wilmink M, Simon LS, Conaghan PG. Malone A, et al. Among authors: simon ls. Lancet Rheumatol. 2024 Dec;6(12):e860-e870. doi: 10.1016/S2665-9913(24)00223-6. Epub 2024 Oct 11. Lancet Rheumatol. 2024. PMID: 39401503 Free article. Clinical Trial.
"I couldn't carry on taking a drug like that": A qualitative study of patient perspectives on side effects from rheumatology drugs.
Berthelsen DB, Nielsen SM, Rasmussen MU, Voshaar M, Richards P, Bartlett SJ, Hazlewood GS, Shea BJ, Tugwell P, Ellingsen T, Jørgensen TS, Kristensen S, Simon LS, Christensen R, Flurey CA; OMERACT Safety Working Group. Berthelsen DB, et al. Among authors: simon ls. Rheumatology (Oxford). 2024 Apr 13:keae223. doi: 10.1093/rheumatology/keae223. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38613847
Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023.
Shea B, Pardo JP, Grosskleg S, Beaton DE, Conaghan P, Goettsch W, Hofstetter C, Maxwell L, Musaus J, Ollendorf D, Schultz G, Stevens R, Strand V, Tugwell P, Williamson P, Tunis S, Simon LS. Shea B, et al. Among authors: simon ls. Semin Arthritis Rheum. 2024 Jun;66:152438. doi: 10.1016/j.semarthrit.2024.152438. Epub 2024 Mar 16. Semin Arthritis Rheum. 2024. PMID: 38555726
Embracing unity at OMERACT: Valuing equity, promoting diversity, fostering inclusivity.
Maxwell LJ, Wright GC, Schultz G, Grosskleg S, Barton JL, Campbell W, Guillemin F, Hofstetter C, Shea BJ, Simon LS, Adebajo A, Barnabe C, Goel N, Hurley P, Nikiphorou E, Petkovic J, Tugwell P. Maxwell LJ, et al. Among authors: simon ls. Semin Arthritis Rheum. 2024 Jun;66:152422. doi: 10.1016/j.semarthrit.2024.152422. Epub 2024 Feb 29. Semin Arthritis Rheum. 2024. PMID: 38461757
238 results